Percutaneous Left Ventricular Assist Device . Intra-aortic Balloon Pump in Patients with Severe Left Ventricular Dysfunction Undergoing Cardiovascular Intervention: A Meta-analysis

Overview

Journal Chronic Dis Transl Med

Publisher Wiley

Date 2019 Jan 4

PMID 30603744

Citations 1

Authors

Fang-Bin Hu

Lian-Qun Cui

Affiliations

Soon will be listed here.

Abstract

Objective: Although controversial, the intra-aortic balloon pump (IABP) and percutaneous left ventricular assist device (PLVAD) are widely used for initial hemodynamic stabilization. We performed a meta-analysis to compare the clinical outcomes of these two devices in patients with severe left ventricular (LV) dysfunction undergoing percutaneous coronary intervention (PCI) or ventricular tachycardia (VT) ablation.

Methods: MEDLINE, EMBASE, the Cochrane Registry of Controlled Trials, and reference lists of relevant articles were searched. We included randomized controlled trials (RCTs) and prospective observational studies. Meta-analysis was conducted using a random effects model.

Results: The quantitative analysis included 4 RCTs and 2 observational studies. A total of 348 patients received PLVAD and 340 received IABP. Meta-analysis revealed that early mortality rates (in-hospital or 30-day) did not differ between the PLVAD and IABP groups (relative risk () = 1.03, 95% confidence interval () = 0.70-1.51, = 0.89). Significant differences were observed between the two groups in the composite, in-hospital, non-major adverse cardiac and cerebrovascular events (MACCE) rate ( = 1.30, 95% = 1.01-1.68, = 0.04).

Conclusions: Compared with IABP, PLVAD with active circulatory support did not improve early survival in those with severe left ventricular dysfunction undergoing either PCI or VT ablation, but increased the in-hospital non-MACCE rate.

Citing Articles

Percutaneous mechanical circulatory support devices in high-risk patients undergoing percutaneous coronary intervention: A meta-analysis of randomized trials.

Shi W, Wang W, Wang K, Huang W Medicine (Baltimore). 2019; 98(37):e17107.

PMID: 31517843 PMC: 6750338. DOI: 10.1097/MD.0000000000017107.

References

Barron H, Every N, Parsons L, Angeja B, Goldberg R, Gore J . The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2. Am Heart J. 2001; 141(6):933-9. DOI: 10.1067/mhj.2001.115295. View

Hochman J . Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. Circulation. 2003; 107(24):2998-3002. DOI: 10.1161/01.CIR.0000075927.67673.F2. View

Thiele H, Sick P, Boudriot E, Diederich K, Hambrecht R, Niebauer J . Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J. 2005; 26(13):1276-83. DOI: 10.1093/eurheartj/ehi161. View

Feldman T, Hirshfeld Jr J, Kern M, King 3rd S, Morrison D, ONeill W . ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention-Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001.... J Am Coll Cardiol. 2006; 47(1):216-35. DOI: 10.1016/j.jacc.2005.11.025. View

Burkhoff D, Cohen H, Brunckhorst C, ONeill W . A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am Heart J. 2006; 152(3):469.e1-8. DOI: 10.1016/j.ahj.2006.05.031. View

Fox K, Steg P, Eagle K, Goodman S, Anderson Jr F, Granger C . Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. JAMA. 2007; 297(17):1892-900. DOI: 10.1001/jama.297.17.1892. View

Sjauw K, Engstrom A, Henriques J . Percutaneous mechanical cardiac assist in myocardial infarction. Where are we now, where are we going?. Acute Card Care. 2007; 9(4):222-30. DOI: 10.1080/17482940701534818. View

Henriques J, de Mol B . New percutaneous mechanical left ventricular support for acute MI: the AMC MACH program. Nat Clin Pract Cardiovasc Med. 2007; 5(2):62-3. DOI: 10.1038/ncpcardio1060. View

Lam K, Sjauw K, van der Meulen J, Symersky P, Biervliet J, Henriques J . A combined surgical and percutaneous approach through the axillary artery to introduce the Impella LP5.0 for short-term circulatory support. Int J Cardiol. 2008; 134(2):277-9. DOI: 10.1016/j.ijcard.2007.12.112. View

10.

Seyfarth M, Sibbing D, Bauer I, Frohlich G, Bott-Flugel L, Byrne R . A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol. 2008; 52(19):1584-8. DOI: 10.1016/j.jacc.2008.05.065. View

11.

Sjauw K, Engstrom A, Vis M, van der Schaaf R, Baan Jr J, Koch K . A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines?. Eur Heart J. 2009; 30(4):459-68. DOI: 10.1093/eurheartj/ehn602. View

12.

Thiele H, Schuler G . Cardiogenic shock: to pump or not to pump?. Eur Heart J. 2009; 30(4):389-90. DOI: 10.1093/eurheartj/ehp030. View

13.

Cheng J, den Uil C, Hoeks S, van der Ent M, Jewbali L, van Domburg R . Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials. Eur Heart J. 2009; 30(17):2102-8. DOI: 10.1093/eurheartj/ehp292. View

14.

Kushner F, Hand M, Smith Jr S, King 3rd S, Anderson J, Antman E . 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating the.... Circulation. 2009; 120(22):2271-306. DOI: 10.1161/CIRCULATIONAHA.109.192663. View

15.

Abuissa H, Roshan J, Lim B, Asirvatham S . Use of the Impella microaxial blood pump for ablation of hemodynamically unstable ventricular tachycardia. J Cardiovasc Electrophysiol. 2009; 21(4):458-61. DOI: 10.1111/j.1540-8167.2009.01673.x. View

16.

Thiele H, Allam B, Chatellier G, Schuler G, Lafont A . Shock in acute myocardial infarction: the Cape Horn for trials?. Eur Heart J. 2010; 31(15):1828-35. DOI: 10.1093/eurheartj/ehq220. View

17.

Perera D, Stables R, Thomas M, Booth J, Pitt M, Blackman D . Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention: a randomized controlled trial. JAMA. 2010; 304(8):867-74. DOI: 10.1001/jama.2010.1190. View

18.

Mahmoudi M, Syed A, Waksman R . The role of percutaneous circulatory assist devices in acute myocardial infarction and high-risk percutaneous coronary intervention in the 21st century. Cardiovasc Revasc Med. 2010; 12(4):237-42. DOI: 10.1016/j.carrev.2010.10.003. View

19.

Engstrom A, Cocchieri R, Driessen A, Sjauw K, Vis M, Baan J . The Impella 2.5 and 5.0 devices for ST-elevation myocardial infarction patients presenting with severe and profound cardiogenic shock: the Academic Medical Center intensive care unit experience. Crit Care Med. 2011; 39(9):2072-9. DOI: 10.1097/CCM.0b013e31821e89b5. View

20.

Jacobs J, Edwards F, Shahian D, Prager R, Wright C, Puskas J . Successful linking of the Society of Thoracic Surgeons database to social security data to examine survival after cardiac operations. Ann Thorac Surg. 2011; 92(1):32-7. DOI: 10.1016/j.athoracsur.2011.02.029. View